Skip to content
Sign In

Main Navigation

James Sharp Logo
  • Individuals
    Individuals

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service
  • Charities & Trustees
    Charities & Trustees

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • Companies
    Companies

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • News & Insights
    • News & Insights
    • Current Research Coverage List
  • About Us
    • About Us
    • Our People
  • Conectus Portal
  • Contact Us

Market News - Page 112

8 August 2024

Assura Plc – Acquisition Of UK Private Hospital Portfolio

ASSURA PLC ANNOUNCES ACQUISITION OF UK PRIVATE HOSPITAL PORTFOLIO FOR £500M FROM NORTHWEST HEALTHCARE PROPERTIES REIT The Board of Assura plc (“Assura“, the “Company” or “Group“) (the “Board“)…

8 August 2024

Allianz Technology Trust – Half-Year Report

ALLIANZ TECHNOLOGY TRUST PLC HALF-YEARLY FINANCIAL REPORT For the six months ended 30 June 2024 HIGHLIGHTS ·      Net Asset Value total return of 28.0% and…

7 August 2024

Netcall Plc – Acquisition of Govtech Holdings Limited

NETCALL PLC (“Netcall”, the “Company” or the “Group”) Acquisition of Govtech Holdings Limited Extending Local Government footprint and enhancing Liberty portfolio with innovative digital solutions…

7 August 2024

Goodwin Plc – Preliminary results

GOODWIN PLC PRELIMINARY ANNOUNCEMENT FOR RELEASE ON 7TH AUGUST 2024 Goodwin PLC today announces its preliminary results for the year ended 30th April, 2024….

6 August 2024

Hargreaves Services – Preliminary Results

Hargreaves Services plc (“Hargreaves”, the “Company”, or the “Group”) Results for the year ended 31 May 2024 Hargreaves Services plc (AIM: HSP), a diversified group…

6 August 2024

GSK Plc – Statement: Zantac (ranitidine) litigation

Statement: Zantac (ranitidine) litigation – Joiner case ·   Jury in Joiner case in Illinois state court finds GSK not liable for plaintiff’s colorectal cancer ·   Verdict is consistent…

2 August 2024

GSK Plc – FDA Expands Jemperli Approval

US FDA expands Jemperli (dostarlimab) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer as the first and only immuno-oncology-based treatment…

1 August 2024

Caledonia Investments – Transaction in own shares

Caledonia Investments plc Transaction in own shares Caledonia Investments plc (“Caledonia”) announces that on 31 July 2024 it purchased from Winterflood Securities Limited 15,772…

Posts navigation

  • «
  • 1
  • …
  • 110
  • 111
  • 112
  • 113
  • 114
  • …
  • 907
  • »

Home > Market News > Page 112

James Sharp white Logo
Sign In
Linkedin Icon

The Exchange
5 Bank Street
Bury, Lancashire
BL9 0DN

Tel: 0161 764 4043

Fax: 0161 764 1628

Email: mail@jamessharp.co.uk

Linkedin Icon

James Sharp & Co is a trading name
of James Sharp & Co LLP (0C422665)

Members of the LLP are referred to as Partners

  • Downloads & Resources
  • Complaints
  • Financial Compensation Scheme
  • Conectus Portal

  • Cyber Essentials Certification
  • Website Terms & Conditions
  • Privacy Policy
  • Cookie policy
  • Consent Preferences

Email Newsletter Sign-up

Consent(Required)
What we do with you information. Find out more

© Copyright 2010-2026. All rights reserved. James Sharp & Co. Authorised & Regulated by the Financial Conduct Authority
Member of the London Stock Exchange - Member of the Aquis Stock Exchange - Member of PIMFA

Website by ICG